Dumont & Blake Investment Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Sell
27,273
-2,266
-8% -$183K 0.52% 52
2026
Q1
$2.09M Sell
29,539
-466
-2% -$34.9K 0.52% 54
2025
Q4
$2.37M Sell
30,005
-274
-0.9% -$21.7K 0.57% 44
2025
Q3
$2.49M Sell
30,279
-52
-0.2% -$4.09K 0.6% 42
2025
Q2
$2.44M Sell
30,331
-30
-0.1% -$2.31K 0.64% 39
2025
Q1
$2.44M Buy
30,361
+50
+0.2% +$4.16K 0.68% 34
2024
Q4
$2.48M Sell
30,311
-211
-0.7% -$17.6K 0.67% 35
2024
Q3
$2.52M Sell
30,522
-30,672
-50% -$2.29M 0.67% 35
2024
Q2
$4.3M Buy
61,194
+30,496
+99% +$2.18M 0.61% 37
2024
Q1
$2.28M Buy
30,698
+48
+0.2% +$3.35K 0.65% 37
2023
Q4
$2.03M Sell
30,650
-1,135
-4% -$71K 0.63% 40
2023
Q3
$2M Sell
31,785
-87
-0.3% -$5.42K 0.68% 39
2023
Q2
$1.8M Sell
31,872
-456
-1% -$25.3K 0.59% 44
2023
Q1
$1.87M Sell
32,328
-145
-0.4% -$9.79K 0.63% 41
2022
Q4
$2.35M Sell
32,473
-901
-3% -$64.5K 0.83% 28
2022
Q3
$2.03M Sell
33,374
-2,223
-6% -$142K 0.76% 33
2022
Q2
$2.23M Sell
35,597
-366
-1% -$24.2K 0.73% 35
2022
Q1
$2.53M Sell
35,963
-8,407
-19% -$568K 0.69% 37
2021
Q4
$2.77M Buy
44,370
+152
+0.3% +$9.54K 0.72% 34
2021
Q3
$2.73M Buy
44,218
+105
+0.2% +$6.32K 0.78% 30
2021
Q2
$2.64M Buy
44,113
+104
+0.2% +$6.59K 0.75% 33
2021
Q1
$2.67M Buy
44,009
+442
+1% +$24.4K 0.82% 30
2020
Q4
$2.04M Sell
43,567
-934
-2% -$40.5K 0.7% 38
2020
Q3
$1.65M Sell
44,501
-666
-1% -$25.3K 0.63% 42
2020
Q2
$1.65M Buy
45,167
+535
+1% +$18.6K 0.69% 40
2020
Q1
$1.36M Buy
44,632
+2,488
+6% +$110K 0.7% 44
2019
Q4
$2.15M Buy
42,144
+846
+2% +$40.8K 0.84% 30
2019
Q3
$1.95M Sell
41,298
-605
-1% -$28.8K 0.82% 31
2019
Q2
$2.08M Buy
41,903
+52
+0.1% +$2.44K 0.87% 30
2019
Q1
$1.78M Buy
41,851
+702
+2% +$31K 0.75% 35
2018
Q4
$1.69M Sell
41,149
-3,638
-8% -$156K 0.79% 35
2018
Q3
$2.09M Buy
44,787
+745
+2% +$34K 0.82% 32
2018
Q2
$1.92M Buy
44,042
+988
+2% +$46.1K 0.81% 35
2018
Q1
$1.98M Sell
43,054
-180
-0.4% -$8.73K 0.84% 33
2017
Q4
$2.19M Buy
43,234
+520
+1% +$27.4K 0.89% 28
2017
Q3
$2.22M Sell
42,714
-6,137
-13% -$299K 0.95% 27
2017
Q2
$2.39M Buy
48,851
+364
+0.8% +$16.9K 1.06% 23
2017
Q1
$2.28M Buy
48,487
+168
+0.3% +$8.01K 1.03% 22
2016
Q4
$2.32M Sell
48,319
-140
-0.3% -$6.42K 1.09% 22
2016
Q3
$1.92M Buy
48,459
+1,644
+4% +$61.8K 0.94% 26
2016
Q2
$1.66M Buy
46,815
+110
+0.2% +$4.29K 0.83% 35
2016
Q1
$1.83M Buy
46,705
+706
+2% +$26.4K 0.95% 29
2015
Q4
$1.98M Buy
45,999
+1,610
+4% +$70.8K 1.01% 24
2015
Q3
$1.86M Buy
44,389
+335
+0.8% +$15.7K 1.01% 25
2015
Q2
$2.2M Buy
44,054
+168
+0.4% +$7.96K 1.07% 23
2015
Q1
$1.98M Buy
43,886
+124
+0.3% +$5.57K 0.96% 27
2014
Q4
$2.11M Buy
43,762
+112
+0.3% +$5.32K 1.04% 26
2014
Q3
$2.09M Sell
43,650
-56
-0.1% -$2.72K 1.08% 24
2014
Q2
$2.16M Sell
43,706
-1,465
-3% -$68.6K 1.09% 23
2014
Q1
$2.13M Sell
45,171
-1,149
-2% -$52.8K 1.11% 23
2013
Q4
$2.23M Sell
46,320
-4,815
-9% -$216K 1.15% 18
2013
Q3
$2.14M Buy
51,135
+129
+0.3% +$5.56K 1.02% 25
2013
Q2
$2.08M Buy
+51,006
New +$1.88M 1.25% 18

Other funds holding MET

Dumont & Blake Investment Advisors's MET Position: Q2 2026 in Review

Dumont & Blake Investment Advisors reduced its MetLife (MET) stake by 7.7% in Q2 2026, selling an estimated $183K and leaving 27,273 shares worth $2.31M. The position accounts for 0.52% of the portfolio, ranked #52.

Dumont & Blake Investment Advisors first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.3M in Q2 2024. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Dumont & Blake Investment Advisors held 27,273 shares of MetLife worth $2.31M as of Q2 2026.
  • Dumont & Blake Investment Advisors sold 2,266 MetLife shares in Q2 2026, an estimated $183K.
  • MetLife made up 0.52% of Dumont & Blake Investment Advisors's portfolio in Q2 2026, its #52 holding.
  • Dumont & Blake Investment Advisors first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
  • Dumont & Blake Investment Advisors's MetLife position peaked at $4.3M in Q2 2024.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.